Life Healthcare Group Holdings Limited (LTGHY)
OTCMKTS · Delayed Price · Currency is USD
2.780
+0.020 (0.72%)
Feb 12, 2026, 11:29 AM EST
LTGHY Income Statement
Financials in millions ZAR. Fiscal year is October - September.
Millions ZAR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Revenue | 25,104 | 23,674 | 22,641 | 20,526 | 26,885 |
Other Revenue | 294 | 272 | 249 | 224 | 174 |
| 25,398 | 23,946 | 22,890 | 20,750 | 27,059 | |
Revenue Growth (YoY) | 6.06% | 4.61% | 10.31% | -23.32% | 12.73% |
Cost of Revenue | 18,341 | 17,254 | 16,409 | 14,877 | 18,705 |
Gross Profit | 7,057 | 6,692 | 6,481 | 5,873 | 8,354 |
Selling, General & Admin | 2,188 | 1,957 | 2,016 | 1,784 | 2,025 |
Amortization of Goodwill & Intangibles | 175 | 154 | 158 | 118 | 533 |
Other Operating Expenses | 764 | 797 | 652 | 642 | 1,017 |
Operating Expenses | 4,529 | 4,280 | 3,992 | 3,554 | 5,453 |
Operating Income | 2,528 | 2,412 | 2,489 | 2,319 | 2,901 |
Interest Expense | -363 | -425 | -604 | -342 | -549 |
Interest & Investment Income | 148 | 240 | 71 | 39 | 25 |
Earnings From Equity Investments | -1 | 10 | 9 | 10 | 25 |
Currency Exchange Gain (Loss) | 201 | 87 | 75 | -138 | 19 |
Other Non Operating Income (Expenses) | -94 | -75 | -70 | -77 | -85 |
EBT Excluding Unusual Items | 2,419 | 2,249 | 1,970 | 1,811 | 2,336 |
Merger & Restructuring Charges | -14 | -11 | -12 | -1 | -3 |
Gain (Loss) on Sale of Investments | - | - | - | - | 28 |
Gain (Loss) on Sale of Assets | 54 | - | -9 | -3 | -17 |
Asset Writedown | -215 | -25 | 3 | - | -14 |
Other Unusual Items | -2,881 | -63 | -54 | 364 | - |
Pretax Income | -620 | 2,170 | 1,911 | 2,191 | 2,409 |
Income Tax Expense | 721 | 636 | 483 | 703 | 642 |
Earnings From Continuing Operations | -1,341 | 1,534 | 1,428 | 1,488 | 1,767 |
Earnings From Discontinued Operations | 5,312 | 3,413 | -990 | 226 | 87 |
Net Income to Company | 3,971 | 4,947 | 438 | 1,714 | 1,854 |
Minority Interest in Earnings | -107 | -120 | -174 | -183 | -100 |
Net Income | 3,864 | 4,827 | 264 | 1,531 | 1,754 |
Preferred Dividends & Other Adjustments | 87 | 83 | - | - | - |
Net Income to Common | 3,777 | 4,744 | 264 | 1,531 | 1,754 |
Net Income Growth | -19.95% | 1728.41% | -82.76% | -12.71% | - |
Shares Outstanding (Basic) | 1,436 | 1,443 | 1,442 | 1,447 | 1,454 |
Shares Outstanding (Diluted) | 1,436 | 1,443 | 1,454 | 1,454 | 1,458 |
Shares Change (YoY) | -0.50% | -0.75% | - | -0.30% | -0.09% |
EPS (Basic) | 2.63 | 3.29 | 0.18 | 1.06 | 1.21 |
EPS (Diluted) | 2.63 | 3.29 | 0.18 | 1.05 | 1.20 |
EPS Growth | -19.98% | 1704.78% | -82.71% | -12.41% | - |
Free Cash Flow | 3,387 | 3,522 | 3,457 | 2,921 | 3,435 |
Free Cash Flow Per Share | 2.36 | 2.44 | 2.38 | 2.01 | 2.35 |
Dividend Per Share | 0.560 | 0.500 | 0.440 | 0.400 | 0.250 |
Dividend Growth | 12.00% | 13.64% | 10.00% | 60.00% | - |
Gross Margin | 27.79% | 27.95% | 28.31% | 28.30% | 30.87% |
Operating Margin | 9.95% | 10.07% | 10.87% | 11.18% | 10.72% |
Profit Margin | 14.87% | 19.81% | 1.15% | 7.38% | 6.48% |
Free Cash Flow Margin | 13.34% | 14.71% | 15.10% | 14.08% | 12.69% |
EBITDA | 3,543 | 3,338 | 3,369 | 3,082 | 4,425 |
EBITDA Margin | 13.95% | 13.94% | 14.72% | 14.85% | 16.35% |
D&A For EBITDA | 1,015 | 926 | 880 | 763 | 1,524 |
EBIT | 2,528 | 2,412 | 2,489 | 2,319 | 2,901 |
EBIT Margin | 9.95% | 10.07% | 10.87% | 11.18% | 10.72% |
Effective Tax Rate | - | 29.31% | 25.27% | 32.09% | 26.65% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.